Status:
NOT_YET_RECRUITING
Clinical Efficacy of Prophylactic Intravenous Neostigmine and Atropine in Preventing Post-Dural Puncture Headache Among Parturient Undergoing Spinal Anesthesia for Cesarean Section: A Double-blind Randomized Placebo-controlled Trial
Lead Sponsor:
Minia University
Conditions:
Acute Pain
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
Post dural puncture headache is a distressing issue, many measures tried to treat symptoms but few delt with prevention.
Eligibility Criteria
Inclusion
- Parturient ladies
- Age ranges from 18 to 35 years old.
- ASA II with elective caesarean section under sub-arachnoid block
Exclusion
- BMI \>35
- Refusal to participate
- surgical complications necessitating a blood transfusion
- Emergency caesarean section
- the need for endotracheal intubation or vasopressors
- any contraindication to regional anesthesia (such as a history of persistent cephalgia, convulsions, cerebrovascular events
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 16 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06493838
Start Date
July 15 2024
End Date
January 16 2025
Last Update
July 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.